These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 21493753)

  • 21. Hepatic Aryl Hydrocarbon Receptor Attenuates Fibroblast Growth Factor 21 Expression.
    Girer NG; Murray IA; Omiecinski CJ; Perdew GH
    J Biol Chem; 2016 Jul; 291(29):15378-87. PubMed ID: 27226639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CH223191 is a ligand-selective antagonist of the Ah (Dioxin) receptor.
    Zhao B; Degroot DE; Hayashi A; He G; Denison MS
    Toxicol Sci; 2010 Oct; 117(2):393-403. PubMed ID: 20634293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Naturally occurring marine brominated indoles are aryl hydrocarbon receptor ligands/agonists.
    DeGroot DE; Franks DG; Higa T; Tanaka J; Hahn ME; Denison MS
    Chem Res Toxicol; 2015 Jun; 28(6):1176-85. PubMed ID: 26001051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kynurenic acid is a potent endogenous aryl hydrocarbon receptor ligand that synergistically induces interleukin-6 in the presence of inflammatory signaling.
    DiNatale BC; Murray IA; Schroeder JC; Flaveny CA; Lahoti TS; Laurenzana EM; Omiecinski CJ; Perdew GH
    Toxicol Sci; 2010 May; 115(1):89-97. PubMed ID: 20106948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The uremic toxin 3-indoxyl sulfate is a potent endogenous agonist for the human aryl hydrocarbon receptor.
    Schroeder JC; Dinatale BC; Murray IA; Flaveny CA; Liu Q; Laurenzana EM; Lin JM; Strom SC; Omiecinski CJ; Amin S; Perdew GH
    Biochemistry; 2010 Jan; 49(2):393-400. PubMed ID: 20000589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The aryl hydrocarbon receptor directly regulates expression of the potent mitogen epiregulin.
    Patel RD; Kim DJ; Peters JM; Perdew GH
    Toxicol Sci; 2006 Jan; 89(1):75-82. PubMed ID: 16192470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adaptation of the human aryl hydrocarbon receptor to sense microbiota-derived indoles.
    Hubbard TD; Murray IA; Bisson WH; Lahoti TS; Gowda K; Amin SG; Patterson AD; Perdew GH
    Sci Rep; 2015 Aug; 5():12689. PubMed ID: 26235394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Putative link between transcriptional regulation of IgM expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin and the aryl hydrocarbon receptor/dioxin-responsive enhancer signaling pathway.
    Sulentic CE; Holsapple MP; Kaminski NE
    J Pharmacol Exp Ther; 2000 Nov; 295(2):705-16. PubMed ID: 11046109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The aryl hydrocarbon receptor suppresses cigarette-smoke-induced oxidative stress in association with dioxin response element (DRE)-independent regulation of sulfiredoxin 1.
    Sarill M; Zago M; Sheridan JA; Nair P; Matthews J; Gomez A; Roussel L; Rousseau S; Hamid Q; Eidelman DH; Baglole CJ
    Free Radic Biol Med; 2015 Dec; 89():342-57. PubMed ID: 26408075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The glycogen synthase kinase inhibitor 3-(2,4-dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione (SB216763) is a partial agonist of the aryl hydrocarbon receptor.
    Braeuning A; Buchmann A
    Drug Metab Dispos; 2009 Aug; 37(8):1576-80. PubMed ID: 19448134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diverse chemicals including aryl hydrocarbon receptor ligands modulate transcriptional activity of the 3'immunoglobulin heavy chain regulatory region.
    Henseler RA; Romer EJ; Sulentic CE
    Toxicology; 2009 Jun; 261(1-2):9-18. PubMed ID: 19447539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integration of genome-wide computation DRE search, AhR ChIP-chip and gene expression analyses of TCDD-elicited responses in the mouse liver.
    Dere E; Lo R; Celius T; Matthews J; Zacharewski TR
    BMC Genomics; 2011 Jul; 12():365. PubMed ID: 21762485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In silico identification of an aryl hydrocarbon receptor antagonist with biological activity in vitro and in vivo.
    Parks AJ; Pollastri MP; Hahn ME; Stanford EA; Novikov O; Franks DG; Haigh SE; Narasimhan S; Ashton TD; Hopper TG; Kozakov D; Beglov D; Vajda S; Schlezinger JJ; Sherr DH
    Mol Pharmacol; 2014 Nov; 86(5):593-608. PubMed ID: 25159092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-throughput evaluation of aryl hydrocarbon receptor-binding sites selected via chromatin immunoprecipitation-based screening in Hepa-1c1c7 cells stimulated with 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Kinehara M; Fukuda I; Yoshida K; Ashida H
    Genes Genet Syst; 2008 Dec; 83(6):455-68. PubMed ID: 19282623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo effects of the pure aryl hydrocarbon receptor antagonist GNF-351 after oral administration are limited to the gastrointestinal tract.
    Fang ZZ; Krausz KW; Nagaoka K; Tanaka N; Gowda K; Amin SG; Perdew GH; Gonzalez FJ
    Br J Pharmacol; 2014 Apr; 171(7):1735-46. PubMed ID: 24417285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ah receptor antagonism represses head and neck tumor cell aggressive phenotype.
    DiNatale BC; Smith K; John K; Krishnegowda G; Amin SG; Perdew GH
    Mol Cancer Res; 2012 Oct; 10(10):1369-79. PubMed ID: 22912337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo antagonism of AhR-mediated gene induction by 3'-methoxy-4'-nitroflavone in TCDD-responsive lacZ mice.
    Nazarenko DA; Dertinger SD; Gasiewicz TA
    Toxicol Sci; 2001 Jun; 61(2):256-64. PubMed ID: 11353134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aryl hydrocarbon receptor-independent activation of estrogen receptor-dependent transcription by 3-methylcholanthrene.
    Shipley JM; Waxman DJ
    Toxicol Appl Pharmacol; 2006 Jun; 213(2):87-97. PubMed ID: 16257430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nuclear transport of the human aryl hydrocarbon receptor and subsequent gene induction relies on its residue histidine 291.
    Tkachenko A; Bermudez M; Irmer-Stooff S; Genkinger D; Henkler-Stephani F; Wolber G; Luch A
    Arch Toxicol; 2018 Mar; 92(3):1151-1160. PubMed ID: 29164305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen receptor subtype- and promoter-specific modulation of aryl hydrocarbon receptor-dependent transcription.
    Wihlén B; Ahmed S; Inzunza J; Matthews J
    Mol Cancer Res; 2009 Jun; 7(6):977-86. PubMed ID: 19470599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.